ANISINA (ATMA potential new class of cytotoxic chemotherapy targeting the cytoskeleton  Preclinical studies show that Anisina enhances the killing effect of anti-microtubule drugs (taxanes and vinca alkaloids)

First Page		Document Content
Cytoskeleton Actin Tropomyosin Chemotherapy Microtubule Taxane Docetaxel Vinblastine Microfilament Cytoskeletal drugs Discovery and development of tubulin inhibitors		ANISINA (ATMA potential new class of cytotoxic chemotherapy targeting the cytoskeleton  Preclinical studies show that Anisina enhances the killing effect of anti-microtubule drugs (taxanes and vinca alkaloids) Add to Reading List Source URL: www.novogen.com Download Document from Source Website File Size: 646,57 KB Share Document on Facebook

	Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th DocID: 1uZFZ - View Document
	MOLECULAR CARCINOGENESIS Taxane-Induced Hedgehog Signaling is Linked to Expansion of Breast Cancer Stem-Like Populations After Chemotherapy Jennifer Sims-Mourtada,1,2* Lynn M. Opdenaker,1, 3 Joshua Davis,1, 3 Kimberly M DocID: 1sAC8 - View Document
	Annals of Oncology Advance Access published August 8, 2012 review Annals of Oncology 00: 1–8, 2012 doi:annonc/mds170 DocID: 1prgZ - View Document
	ANISINA (ATMA potential new class of cytotoxic chemotherapy targeting the cytoskeleton  Preclinical studies show that Anisina enhances the killing effect of anti-microtubule drugs (taxanes and vinca alkaloids) DocID: 1ph49 - View Document
	Registered report: androgen receptor splice variants determine taxane sensitivity in prostate cancer Xiaochuan Shan1 , Gwenn Danet-Desnoyers1 , Juan Jos´e Fung2 , Alan H. Kosaka2 , Fraser Tan3 , Nicole Perfito3 , Joelle DocID: 1lWYj - View Document